LIST OF FIGURES
LIST OF CHARTS
EXECUTIVE SUMMARY
EUROPEAN UROLOGICAL DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
MARKETS INCLUDED
PROCEDURES INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.1.1 Human Urinary System
2.2 URINARY PATHOLOGY AND DISORDERS
2.2.1 Benign Prostate Hyperplasia (BPH)
2.2.2 Urinary Incontinence
2.2.3 Urinary Tract Infections (UTI)
2.2.4 Kidney Stones
2.2.5 Bladder Prolapse
2.2.6 Overactive Bladder
2.2.7 Prostatitis
2.2.8 Erectile Dysfunction (ED)
2.2.9 Cancer
2.2.9.1.1 Prostate Cancer
2.2.9.1.2 Bladder Cancer
2.3 PATIENT DEMOGRAPHICS
2.3.1 Benign Prostatic Hyperplasia
2.3.2 Urinary Incontinence
2.3.3 UTI
2.3.4 Kidney Stones
2.3.5 Erectile Dysfunction
2.3.6 Overactive Bladder
2.3.7 Prostatitis
2.3.8 Cancer
2.3.8.1 Prostate Cancer
2.3.8.2 Bladder Cancer
PRODUCT ASSESSMENT
3.1 PRODUCT PORTFOLIOS
3.1.1 Urologoical Endoscope
3.1.1.1.1 Cystoscope
3.1.1.1.2 Ureteroscope
3.1.1.1.3 Resectoscope
3.1.1.1.4 Nephroscope
3.2 CLINICAL TRIALS
3.2.1 Boston Scientific
3.2.2 C.R. Bard
3.2.3 Coloplast
3.2.4 Dornier MedTech
3.2.5 Ethicon
3.2.6 GE (Oncura)
3.2.7 Hollister
3.2.8 Lumenis
3.2.9 Olympus
3.2.10 Teleflex
3.2.11 WellSpect Healthcare
COUNTRY PROFILES
4.1 INTRODUCTION
4.1.1.1 Population
4.1.1.2 Median Age
4.1.1.3 GDP Per Capita
4.1.1.4 Price Index
4.2 GERMANY
4.3 FRANCE
4.4 UNITED KINGDOM
4.5 ITALY
4.6 SPAIN
4.7 BENELUX
4.8 SCANDINAVIA
4.9 AUSTRIA
4.10 SWITZERLAND
4.11 PORTUGAL
UROLOGICAL ENDOSCOPE MARKET
5.1 INTRODUCTION
5.2 MARKET OVERVIEW
5.3 MARKET ANALYSIS AND FORECAST
5.3.1 Total Urological Endoscope Market
5.3.2 Rigid Cystoscope Market
5.3.3 Total Flexible Cystoscope Market
5.3.3.1 Flexible Fiber Optic Cystoscope Market
5.3.3.2 Flexible Video Cystoscope Market
5.3.4 Semi-Rigid Ureteroscope Market
5.3.5 Total Flexible Ureteroscope Market
5.3.5.1 Flexible Fiber Optic Ureteroscope Market
5.3.5.2 Flexible Video Ureteroscope Market
5.3.6 Rigid Resectoscope Market
5.3.7 Rigid Nephroscope Market
5.4 DRIVERS AND LIMITERS
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
APPENDIX II: COMPANY PRESS RELEASES

Chart 1 1: Total Urological Device Market, Europe, 2012 – 2022
Chart 1 2: Total Urological Device Market Overview, Europe, 2015 & 2022
Chart 4 1: Country Profile, Germany, 2015
Chart 4 2: Country Profile, France, 2015
Chart 4 3: Country Profile, United Kingdom, 2015
Chart 4 4: Country Profile, Italy, 2015
Chart 4 5: Country Profile, Spain, 2015
Chart 4 6: Country Profile, Benelux, 2015
Chart 4 7: Country Profile, Scandinavia, 2015
Chart 4 8: Country Profile, Austria, 2015
Chart 4 9: Country Profile, Switzerland, 2015
Chart 4 10: Country Profile, Portugal, 2015
Chart 5 1: Urological Endoscope Market by Segment, Europe, 2012 – 2022
Chart 5 2: Urological Endoscope Market Breakdown, Europe, 2015
Chart 5 3: Urological Endoscope Market Breakdown, Europe, 2022
Chart 5 4: Total Urological Endoscope Market, Europe, 2012 – 2022
Chart 5 5: Rigid Cystoscope Market, Europe, 2012 – 2022
Chart 5 6: Total Flexible Cystoscope Market, Europe, 2012 – 2022
Chart 5 7: Flexible Fiber Optic Cystoscope Market, Europe, 2012 – 2022
Chart 5 8: Flexible Video Cystoscope Market, Europe, 2012 – 2022
Chart 5 9: Semi-Rigid Ureteroscope Market, Europe, 2012 – 2022
Chart 5 10 Total Flexible Ureteroscope Market, Europe, 2012 – 2022
Chart 5 11: Flexible Fiber Optic Ureteroscope Market, Europe, 2012 – 2022
Chart 5 12: Flexible Video Ureteroscope Market, Europe, 2012 – 2022
Chart 5 13: Rigid Resectoscope Market, Europe, 2012 – 2022
Chart 5 14: Rigid Nephroscope Market, Europe, 2012 – 2022
Chart 5 15: Leading Competitors, Urological Endoscope Market, Europe, 2015

List of Figures
Figure 1 1: Urological Device Competitor Market Share Ranking by Segment, Europe, 2015 (1 of 2)
Figure 1 2: Urological Device Competitor Market Share Ranking by Segment, Europe, 2015 (2 of 2)
Figure 1 3: Companies Mentioned in Report
Figure 1 4: Factors Impacting the Urological Device Market by Segment, Europe (1 of 2)
Figure 1 5: Factors Impacting the Urological Device Market by Segment, Europe (2 of 2)
Figure 1 6: Recent Events in Urological Device Market, Europe, 2012 – 2016
Figure 1 7: Urological Device Markets Covered, Europe, 2015, (Part 1 of 2)
Figure 1 8: Urological Device Markets Covered, Europe, 2015, (Part 2 of 2)
Figure 1 9: Urological Procedures Covered, Europe, 2015
Figure 1 10: Key Report Updates
Figure 1 11: Version History
Figure 3 1: Urological Endoscope Products by Company
Figure 3 2: Safety and Effectiveness of Jetstream Atherectomy System (J-SUPREME)
Figure 3 3: Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology (PINNACLE FLX)
Figure 3 4: Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy (MIRACLEIII)
Figure 3 5: Watchman FLX Left Atrial Appendage Closure Device Post Approval Study
Figure 3 6: Expanding MRI Access for Patients With New and Existing ICDs and CRT-Ds ( ENABLE MRI) (ENABLE MRI)
Figure 3 7: Observation of ImageReady™ MR Conditional Pacing System in China
Figure 3 8: EVOLVE Short DAPT Study
Figure 3 9: ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent (IMPERIAL)
Figure 3 10: CoverEdge Algorithm Programming Study
Figure 3 11: Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement
Figure 3 12: The Captivator EMR Registry
Figure 3 13: FAST Feasibility Study
Figure 3 14: Using the Vessix Renal Denervation System for the Treatment of Hypertension
Figure 3 15: A Study to Evaluate the Effect of Precision Spectra™ Programming
Figure 3 16: Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft
Figure 3 17: Study of Phasix™ Mesh for VHWG Grade 3 Midline Hernia Repair
Figure 3 18: A Single Arm Trial Evaluating the BARD Lutonix Drug-Coated Balloon
Figure 3 19: Korean Post-market Registry Assessing the Clinical Use and Safety of the Lutonix
Figure 3 20: A Prospective Trial of a Bio-absorbable Mesh
Figure 3 21: A Post-Market, Single-Arm Trial of XenMatrix™ AB Surgical Graft
Figure 3 22: BARD® The VENOVO™ Venous Stent Study
Figure 3 23: Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft (AVeNEW)
Figure 3 24: Time and Motion Related to PICC Insertion Process and Catheter Tip Confirmation
Figure 3 25: Prospective Feasibility Trial of AccuCath 2.25 BC
Figure 3 26: Study Comparing Lutonix AV Drug Coated Balloon vs Standard Balloon for Treatment
Figure 3 27: Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
Figure 3 28: Investigation of Two New 1-piece Ostomy Products
Figure 3 29: Investigation of a New 2-piece Ostomy Product
Figure 3 30: Altis® 522 Trial - Treatment of Female Stress Urinary Incontinence
Figure 3 31: ARIES for Vasculogenic Erectile Dysfunction
Figure 3 32: The EVICEL® Neurosurgery Phase III Study
Figure 3 33: Powered Surgical Stapler in VATS Lung Resection Procedures in China
Figure 3 34: Development of a MR Scanner Capable of Being Sited in a Neonatal Intensive Care Unit
Figure 3 35: Clinical Evaluation of a Dual Energy CT System
Figure 3 36: Assessment of a Oral Endotracheal Tube Fastener
Figure 3 37: Utilizing Holmium Laser for FURS Renal Stone Lithotripsy
Figure 3 38: Ablation Efficacy of Contact Side Firing Fiber in Predefined Settings for Treating BPH.
Figure 3 39: Feasibility of IPL for Reducing Dry Eye Symptoms Caused by MGD
Figure 3 40: Radiofrequency Ablation for Multi-level Obstructive Sleep Apnea
Figure 3 41: Evaluation and Control of WAG in PACU Within Patient and Caregiver Breathing Zone
Figure 3 42: Evaluation of a Novel Electronic Transanal Irrigation System - Navina™ Smart
Figure 5 1: Urological Endoscope Market by Segment, Europe, 2012 – 2022 (€M)
Figure 5 2: Urological Endoscope Market by Segment, Europe, 2012 – 2022 (US$M)
Figure 5 3: Total Urological Endoscope Market, Europe, 2012 – 2022 (€ and US$)
Figure 5 4 Rigid Cystoscope Market, Europe, 2012 – 2022 (€ and US$)
Figure 5 5 Total Flexible Cystoscope Market, Europe, 2012 – 2022 (€ and US$)
Figure 5 6: Flexible Fiber Optic Cystoscope Market, Europe, 2012 – 2022 (€ and US$)
Figure 5 7: Flexible Video Cystoscope Market, Europe, 2012 – 2022 (€ and US$)
Figure 5 8: Semi-Rigid Ureteroscope Market, Europe, 2012 – 2022 (€and US$)
Figure 5 9: Total Flexible Ureteroscope Market, Europe, 2012 – 2022 (€and US$)
Figure 5 10: Flexible Fiber Optic Ureteroscope Market, Europe, 2012 – 2022 (€and US$)
Figure 5 11: Flexible Video Ureteroscope Market, Europe, 2012 – 2022 (€and US$)
Figure 5 12: Rigid Resectoscope Market, Europe, 2012 – 2022 (€and US$)
Figure 5 13: Rigid Nephroscope Market, Europe, 2012 – 2022 (€ and US$)
Figure 5 14: Drivers and Limiters, Urological Endoscope Market, Europe, 2015
Figure 5 15: Leading Competitors, Urological Endoscope Market, Europe, 2015
Figure 7 1: Press Release Summary